Clinical Implementation of Novel Kidney Injury Biomarkers for Diagnosis Assessment; the NGAL in a Real-life AKI Setting
Jean-Maxime Côté*, Roxanne Authier, Marie-Claire Bélanger
Acute kidney injury (AKI) is a complex syndrome. Novel kidney injury biomarkers have been shown to improve prognostic and diagnostic assessment, but their use has been mostly limited to research settings.
Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado
